Progyny's earnings call reflects solid growth and a strong financial performance, highlighted by record ART cycles and increased revenue guidance. The company has successfully retained and expanded client relationships while strategically partnering with industry leaders like Amazon. However, challenges such as slower initial pipeline growth and demographic differences in early client wins present areas to monitor.

Company Guidance -

Q3 2025

During the Progyny, Inc. second quarter 2025 earnings call, the company provided detailed guidance for both the third quarter and the full year 2025. The guidance reflects an increase in full-year revenue expectations to a range of $1.235 billion to $1.270 billion, translating to growth of 5.8% to 8.8%. Excluding revenue from a large client under a transition of care agreement, the projected growth is 15.1% to 18.5%. The company anticipates adjusted EBITDA to range from $205.5 million to $214.5 million, with net income between $52.3 million and $58.9 million. Progyny also shared projections for adjusted EPS between $1.70 and $1.78 on approximately 90 million fully diluted shares. For the third quarter, projected revenue is set between $290 million and $305 million, marking a growth of 1% to 6%, but 14% to 20% excluding the transition client. The company expects a third-quarter adjusted EBITDA of $45 million to $49 million and net income of $9.4 million to $12.3 million, translating to adjusted EPS of $0.37 to $0.40. The guidance reflects healthy member engagement and a return to historical seasonal patterns in utilization rates.

Strong Revenue Growth

Second quarter revenue grew 9.5% over the prior year to $332.9 million, primarily driven by an increase in the number of clients and covered lives. Excluding a former client's contribution, revenue increased by 18%.

Record ART Cycles

Nearly 17,000 ART cycles were performed in the second quarter, the highest quarterly total ever, representing a 9% increase over the same period last year.

Raised Full Year Guidance

Due to strong first-half performance, Progyny raised its full-year guidance, now projecting revenue between $1.235 billion to $1.270 billion and adjusted EBITDA between $205.5 million and $214.5 million.

Successful Client Retention and Expansion

Progyny maintained a high rate of client retention with many clients expanding their benefits, reflecting the value seen in improving healthcare efficiency.

Strategic Partnerships and Innovations

Progyny announced a partnership with Amazon as part of their Health Benefits Connector program and continued to develop innovative partnerships, such as with OURA for personalized health data engagement.

Progyny (PGNY) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

Daily Earnings Calendar >

PGNY Earnings History

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change	Slides	Play Transcript
Oct 30, 2025	2025 (Q3)	0.13 / -	0.11	―	―	―
Aug 07, 2025	2025 (Q2)	0.16 / 0.19	0.17	11.76% (+0.02)	―
May 08, 2025	2025 (Q1)	0.19 / 0.17	0.17	0.00% (0.00)	―
Feb 27, 2025	2024 (Q4)	0.10 / 0.12	0.13	-7.69% (-0.01)	―
Nov 12, 2024	2024 (Q3)	0.14 / 0.11	0.16	-31.25% (-0.05)	―
Aug 06, 2024	2024 (Q2)	0.17 / 0.17	0.15	13.33% (+0.02)	―
May 09, 2024	2024 (Q1)	0.13 / 0.17	0.18	-5.56% (>-0.01)	―
Feb 27, 2024	2023 (Q4)	0.11 / 0.13	0.03	333.33% (+0.10)	―
Nov 07, 2023	2023 (Q3)	0.12 / 0.16	0.13	23.08% (+0.03)	―
Aug 03, 2023	2023 (Q2)	0.10 / 0.15	0.09	66.67% (+0.06)	―

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed

PGNY Earnings-Related Price Changes

Report Date	Price 1 Day Before	Price 1 Day After	Percentage Change
Aug 07, 2025	$23.06	$22.85	-0.91%
May 08, 2025	$23.37	$21.19	-9.33%
Feb 27, 2025	$22.88	$22.53	-1.53%
Nov 12, 2024	$17.18	$13.90	-19.09%

Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Progyny (PGNY) report earnings?

Progyny (PGNY) is schdueled to report earning on Oct 30, 2025, After Close (Confirmed).

What is Progyny (PGNY) earnings time?

Progyny (PGNY) earnings time is at Oct 30, 2025, After Close (Confirmed).

Where can I see when companies are reporting earnings?

You can see which companies are reporting today on our designated earnings calendar.

What companies are reporting earnings today?

You can see a list of the companies which are reporting today on TipRanks earnings calendar.

What is PGNY EPS forecast?

PGNY EPS forecast for the fiscal quarter 2025 (Q3) is 0.13.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing